U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215182) titled '[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer' on Sept. 10.
Brief Summary: The goal of this clinical trial is to investigate the use of the tracer [68Ga]Ga-FAPI-46 for PET/CT-imaging in response evaluation of patients with advanced stage malignant melanoma treated with immune checkpoint inhibitor therapy (ICT). The main question it aims to answer is:
* Can [68Ga]Ga-FAPI-46 PET/CT improve response evaluation in patients suffering from advanced stage malignant melanoma treated with ICT and potentially serve as a biomarker.
Researchers will compare findings on the experimental [68Ga]Ga-FAPI-46 PET/CT with fi...